YOLFTbeta
Privia Health Group Inc

Privia Health Group Inc

PRVA · NASDAQ · Healthcare / Health Information Services

24.55USD+0.88 (+3.72%)

Price History

Full chart

Market Stats

Previous Close23.67
Open23.74
Day Range23.58 – 24.75
52-Week Range18.92 – 28.82
Volume1.59M
Market Cap2.52B
P/E (TTM)89.59
Forward P/E17.27
EPS0.22
Dividend Yield0.00%
Beta0.88
50-Day Avg22.11
200-Day Avg23.00

About

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with physician practices, health plans, and health systems. It also offers technology and population health tools to enhance providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; and single-TIN medical group that facilitates negotiating power, clinical integration, and alignment of financial incentives. In addition, the company operates accountable care organization, which engages patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect across platform to better understand the holistic needs of each patient and connect with other providers to address individual medical needs. The company was founded in 2007 and is headquartered in Arlington, Virginia.

Company Details

  • SectorHealthcare
  • IndustryHealth Information Services
  • CEOMr. Parth Mehrotra
  • Employees1.23K
  • Headquarters950 North Glebe Road, Arlington, VA, United States, 22203, USA
  • Websitehttps://www.priviahealth.com

Leadership

  • Mr. Parth MehrotraCEO & Director · b. 1979
  • Mr. David Mountcastle CPA, MBAExecutive VP & CFO · b. 1970
  • Mr. Edward Christopher Fargis Esq.Executive VP, General Counsel, Chief Legal Officer & Corporate Secretary · b. 1965
  • Mr. Sarath DegalaChief Operating Officer
  • Mr. Konda MullapudiExecutive VP & CTO
  • Mr. Robert P. BorchertSenior Vice President of Investor Relations & Corporate Communications
  • Ms. Dana Fields CPAChief Audit & Compliance Officer
  • Ms. Jenny HardingChief People Officer
  • Mr. Jay StevensSenior VP & Chief Growth Officer
  • Mr. Eric J. BeyerExecutive Vice President of Medical Groups

Financials

Income Statement

Currency: USD2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue657.61M786.36M817.08M966.22M1.36B1.66B1.74B2.12B
Growth (%)-+19.58%+3.91%+18.25%+40.41%+22.19%+4.74%+22.26%
Cost of Revenue601.15M717.89M734.49M902.56M1.22B1.50B1.56B1.91B
Gross Profit56.46M68.47M82.58M63.66M134.78M161.50M176.85M209.43M
Gross Margin8.59%8.71%10.11%6.59%9.93%9.74%10.19%9.87%
Operating Expense54.30M52.41M57.20M281.10M153.90M140.85M159.87M175.19M
Operating Income2.15M16.06M25.38M-217.44M-19.12M20.65M16.98M34.23M
Operating Margin0.33%2.04%3.11%-22.50%-1.41%1.25%0.98%1.61%
EBITDA3.23M17.49M27.22M-214.97M-14.01M35.55M35.14M53.84M
EBITDA Margin0.49%2.22%3.33%-22.25%-1.03%2.14%2.02%2.54%
Net Income-3.04M8.24M31.24M-188.23M-8.59M23.08M14.38M22.92M
Net Income Margin-0.46%1.05%3.82%-19.48%-0.63%1.39%0.83%1.08%
Interest Expense6.42M6.91M1.92M1.07M542.00K8.37M--
Interest Expense % of Total Revenue0.98%0.88%0.23%0.11%0.04%0.51%--

Balance Sheet

Currency: USD2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets249.49M270.20M328.97M686.37M792.81M999.90M1.14B1.37B
Total Liabilities163.44M162.75M185.32M236.19M273.76M392.51M452.34M578.43M
Total Equity88.50M110.21M146.75M426.87M499.09M561.44M635.18M737.22M
Cash39.11M46.89M84.63M320.58M347.99M389.51M491.15M479.69M
Total Debt67.00M43.10M33.66M46.50M11.50M8.29M5.59M9.53M
Net Debt27.89M-3.79M-50.97M-274.08M-336.49M-381.22M-485.56M-470.15M

Cash Flow

Currency: USD2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow5.25M24.36M38.89M55.06M47.20M80.78M109.28M163.40M
Investing Cash Flow-165.00K-5.71M-380.00K-32.77M-104.00K-48.01M-10.32M-181.57M
Financing Cash Flow15.36M-10.87M-767.00K213.66M-19.68M8.74M2.68M6.70M
Capital Expenditure220.00K5.71M380.00K547.00K104.00K113.00K5.02M1.20M
Free Cash Flow5.03M18.65M38.51M54.51M47.09M80.67M104.26M162.20M
FCF to OCF95.81%76.56%99.02%99.01%99.78%99.86%95.41%99.27%

Earnings

Report DateMar 3, 2021May 27, 2021Aug 9, 2021Nov 8, 2021Mar 22, 2022May 12, 2022Aug 11, 2022Nov 10, 2022Feb 28, 2023May 4, 2023Aug 3, 2023Nov 3, 2023Feb 27, 2024May 9, 2024Aug 8, 2024Nov 7, 2024Feb 25, 2025May 8, 2025Aug 7, 2025Nov 6, 2025Feb 26, 2026May 7, 2026Aug 6, 2026Nov 5, 2026
EPS Estimate0.080.04-1.55-0.15-0.130.090.100.12-0.030.140.140.160.040.150.180.200.200.180.050.220.040.250.080.09
EPS Actual0.100.06-1.68-0.10-0.110.120.130.130.140.160.170.170.020.180.190.200.210.220.020.290.070.190.07-
Surprise25.00%50.00%-8.39%33.33%15.38%33.33%30.00%8.33%566.67%14.29%21.43%6.25%-50.00%20.00%5.56%0.00%4.58%22.22%-60.00%31.82%75.00%-24.00%-12.50%-
Timing-After-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap2.52B
Enterprise Value2.04B
Trailing P/E89.59
Forward P/E17.27
Price / Sales1.07
Price / Book3.12
EPS0.22
Book Value6.20
Revenue (TTM)2.36B
Gross Profit (TTM)236.52M
EBITDA56.94M
Profit Margin1.19%
Operating Margin1.86%
Return on Equity4.31%
Return on Assets2.03%
Shares Outstanding127.73M
Shares Float108.95M
Beta0.88
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 21 analystsTarget 31.47
  • Strong Buy
    14
  • Buy
    5
  • Hold
    2

Ownership Breakdown

Institutions
98.53%
Insiders
6.19%
Retail / Other
0.00%

Top Institutional Holders

  • BlackRock Inc
    19.06M14.92%
  • FMR Inc
    13.05M10.21%
  • Durable Capital Partners LP
    11.64M9.11%
  • Vanguard Portfolio Management, LLC
    6.28M4.92%
  • Rubicon Founders LLC
    5.95M4.66%
  • Vanguard Capital Management, LLC
    5.01M3.92%
  • State Street Corp
    4.49M3.52%
  • Van Berkom and Associates Inc
    3.71M2.91%
  • Riverbridge Partners LLC
    3.00M2.35%
  • Bank of New York Mellon Corp
    2.94M2.30%
  • Geode Capital Management, LLC
    2.90M2.27%
  • Principal Financial Group Inc
    2.59M2.03%
  • Dimensional Fund Advisors, Inc.
    2.55M2.00%
  • Wellington Management Company LLP
    2.13M1.67%
  • UBS Asset Mgmt Americas Inc
    2.05M1.61%

Top Fund Holders

  • iShares Core S&P Small-Cap ETF
    7.22M5.65%
  • Vanguard MStar Total Stk Mkt Idx Invest
    3.60M2.82%
  • iShares Russell 2000 ETF
    3.10M2.43%
  • Vanguard Small Cap Index
    2.61M2.04%
  • Fidelity Select Health Care
    1.86M1.46%